Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 53.66 3.41% 1.77
ENTA closed up 3.41 percent on Tuesday, February 18, 2020, on 82 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ENTA trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Stochastic Reached Oversold Weakness 3.41%
Outside Day Range Expansion 3.41%
Oversold Stochastic Weakness 3.41%
Hammer Candlestick Bullish 2.27%
Narrow Range Bar Range Contraction 2.27%
NR7 Range Contraction 2.27%
Doji - Bullish? Reversal 1.51%
Fell Below 20 DMA Bearish 1.59%
1,2,3 Retracement Bearish Bearish Swing Setup -3.70%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Chemistry Biotechnology Chemical Compounds Infection Infectious Disease Cyclopropanes Pyrrolidines Hepatitis C Hepatitis C Virus HCV Infection Ns3 Ns5a Viruses

Is ENTA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 106.8
52 Week Low 51.15
Average Volume 191,050
200-Day Moving Average 70.57
50-Day Moving Average 59.06
20-Day Moving Average 54.19
10-Day Moving Average 54.09
Average True Range 1.86
ADX 43.75
+DI 16.11
-DI 32.86
Chandelier Exit (Long, 3 ATRs ) 54.05
Chandelier Exit (Short, 3 ATRs ) 56.73
Upper Bollinger Band 57.73
Lower Bollinger Band 50.66
Percent B (%b) 0.42
BandWidth 13.04
MACD Line -1.60
MACD Signal Line -1.73
MACD Histogram 0.1269
Fundamentals Value
Market Cap 1.02 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -49.69
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.71
Resistance 3 (R3) 57.39 55.73 57.04
Resistance 2 (R2) 55.73 54.70 55.89 56.81
Resistance 1 (R1) 54.69 54.06 55.21 55.01 56.58
Pivot Point 53.03 53.03 53.29 53.19 53.03
Support 1 (S1) 51.99 52.00 52.51 52.31 50.74
Support 2 (S2) 50.33 51.36 50.49 50.51
Support 3 (S3) 49.29 50.33 50.29
Support 4 (S4) 49.61